Literature DB >> 18176898

Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats.

Irena Niebroj-Dobosz1, Janina Rafałowska, Anna Fidziańska, Roman Gadamski, Paweł Grieb.   

Abstract

We present the results of biochemical and electron microscopic (EM) examinations of the spinal cord myelin from SOD1G93A transgenic Sprague Dawley rats in the early and late symptom-free period of the disease (60 and 93 days of life) and after four-leg paralysis has occurred (120 days of life). Biochemical and ultrastructural changes of myelin started already in the symptom-free period and become most pronounced in the paralyzed animals. Biochemical examinations indicated a decrease of lipids, phospholipids, cholesterol and cerebrosides. The pattern of particular phospholipids was in the normal range. A progressive decrease of the percentages of proteolipid, DM-20 and Wolfgram proteins was evident. Myelin basic proteins I and II were less affected. In EM,massive myelin disorganization was observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18176898

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  15 in total

Review 1.  Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

Authors:  Reshmi Tognatta; Robert H Miller
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

2.  Histological-MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis.

Authors:  Mark D Meadowcroft; Nathan J Mutic; Don C Bigler; Jian-Li Wang; Zachary Simmons; James R Connor; Qing X Yang
Journal:  J Magn Reson Imaging       Date:  2014-02-26       Impact factor: 4.813

3.  Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis.

Authors:  Francisco Javier Miana-Mena; Eduardo Piedrafita; Cristina González-Mingot; Pilar Larrodé; María Jesús Muñoz; Enrique Martínez-Ballarín; Russel J Reiter; Rosario Osta; Joaquín J García
Journal:  J Bioenerg Biomembr       Date:  2011-03-31       Impact factor: 2.945

4.  Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie Navarro; Tony E Besong; Kayla J Boccio; Surafuale Hailu; Mohammed Khatib; Paul R Sanberg; Stanley H Appel; Cesario V Borlongan
Journal:  Exp Neurol       Date:  2018-08-30       Impact factor: 5.330

5.  Lipid Metabolism Is Dysregulated in the Motor Cortex White Matter in Amyotrophic Lateral Sclerosis.

Authors:  Gemma L Sadler; Katherine N Lewis; Vinod K Narayana; David P De Souza; Joel Mason; Catriona McLean; David G Gonsalvez; Bradley J Turner; Samantha K Barton
Journal:  Metabolites       Date:  2022-06-17

6.  Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.

Authors:  Shin H Kang; Ying Li; Masahiro Fukaya; Ileana Lorenzini; Don W Cleveland; Lyle W Ostrow; Jeffrey D Rothstein; Dwight E Bergles
Journal:  Nat Neurosci       Date:  2013-03-31       Impact factor: 24.884

7.  Glial cells in amyotrophic lateral sclerosis.

Authors:  Jurate Lasiene; Koji Yamanaka
Journal:  Neurol Res Int       Date:  2011-06-07

Review 8.  Microglia centered pathogenesis in ALS: insights in cell interconnectivity.

Authors:  Dora Brites; Ana R Vaz
Journal:  Front Cell Neurosci       Date:  2014-05-22       Impact factor: 5.505

9.  Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier.

Authors:  David J Eve; George Steiner; Ajay Mahendrasah; Paul R Sanberg; Crupa Kurien; Avery Thomson; Cesar V Borlongan; Svitlana Garbuzova-Davis
Journal:  Oncotarget       Date:  2018-01-31

10.  Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Thomas Philips; Andre Bento-Abreu; Annelies Nonneman; Wanda Haeck; Kim Staats; Veerle Geelen; Nicole Hersmus; Benno Küsters; Ludo Van Den Bosch; Philip Van Damme; William D Richardson; Wim Robberecht
Journal:  Brain       Date:  2013-01-31       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.